GlobalData’s research reveals that India’s glucose monitoring market accounts for about 10 per cent of the Asia-Pacific (APAC) market in 2024, reflecting the growing focus on affordable and innovative solutions tailored to local needs
The growing prevalence of diabetes in India, combined with limited access to reliable monitoring tools, presents a significant public health challenge. Effective glucose monitoring is crucial for disease management, yet affordability and accuracy remain key barriers. Against this backdrop, India’s glucose monitoring market is forecast to grow at a 2 per cent compound annual growth rate (CAGR) during 2024-33, says GlobalData
GlobalData’s research reveals that India’s glucose monitoring market accounts for about 10 per cent of the Asia-Pacific (APAC) market in 2024, reflecting the growing focus on affordable and innovative solutions tailored to local needs.
Kanchan Chauhan, Medical Devices Analyst, GlobalData, comments, “Despite the growing availability of glucose monitoring solutions in India, there remain significant gaps in affordability, user education, and accessibility, particularly in rural areas. Locally manufactured devices can help bridge these gaps, but broader efforts in education and support systems are vital for effective diabetes management.”
The GL 22, manufactured locally, combines German precision with affordability to meet the needs of Indian consumers. With a strong focus on community outreach, Beurer India plans to collaborate with healthcare professionals and organizations to conduct diabetes education programs, health camps, and training sessions to improve access and empower patients with better disease management practices.
Chauhan concludes, “India’s diabetes burden underscores the urgency of addressing gaps in care delivery and promoting consistent disease management. Strengthening healthcare infrastructure and raising awareness at the community level will be key to transforming diabetes management and improving long-term health outcomes across the country.”